Home/Filings/4/0001209191-23-047062
4//SEC Filing

Chudnovsky Yekaterina 4

Accession 0001209191-23-047062

CIK 0001873835other

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 4:28 PM ET

Size

7.9 KB

Accession

0001209191-23-047062

Insider Transaction Report

Form 4
Period: 2023-08-22
Chudnovsky Yekaterina
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-08-22+20,00020,000 total
    Exercise: $1.80Exp: 2033-08-22Common Stock (20,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-08-22+16,67016,670 total
    Exercise: $1.80Exp: 2033-08-22Common Stock (16,670 underlying)
Footnotes (2)
  • [F1]The Stock Option will vest in thirty-six (36) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.
  • [F2]The Stock Option will vest in ten (10) equal monthly installments following the date of grant and any remaining unvested shares will become fully vested and exercisable on the date of the 2024 annual shareholder meeting, subject to the Reporting Person's continued service on the Board of Directors.

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1
  • filerCIK 0001979324

Filing Metadata

Form type
4
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:28 PM ET
Size
7.9 KB